Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

J Lai, Y Lu, Z Yin, F Hu, W Wu - International journal of …, 2010 - Taylor & Francis
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …

Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

J Lai, Y Lu, Z Yin, F Hu, W Wu - International journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …

[PDF][PDF] Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

J Lai - International Journal of Nanomedicine, 2010 - academia.edu
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …

Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.

J Lai, Y Lu, Z Yin, F Hu, W Wu - International Journal of …, 2010 - europepmc.org
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …

[PDF][PDF] Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

J Lai - International Journal of Nanomedicine, 2010 - scienceopen.com
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …

[PDF][PDF] Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

J Lai - International Journal of Nanomedicine, 2010 - scholar.archive.org
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …

Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

J Lai, Y Lu, Z Yin, F Hu, W Wu - International Journal of …, 2009 - dovepress.com
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …

[PDF][PDF] Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

J Lai - International Journal of Nanomedicine, 2010 - pdfs.semanticscholar.org
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …

[PDF][PDF] Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

J Lai - International Journal of Nanomedicine, 2010 - Citeseer
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …

[PDF][PDF] Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

J Lai - International Journal of Nanomedicine, 2010 - researchgate.net
Efforts to improve the oral bioavailability of cyclosporine A (CyA) remains a challenge in the
field of drug delivery. In this study, glyceryl monooleate (GMO)/poloxamer 407 cubic …